CME Group filed suit against the CFTC on Thursday, asking a federal court to vacate the agency's approval of Kalshi's U.S. perpetual futures contracts and to vacate any self-certified products filed on similar grounds. The move came a day after outgoing CEO Terrence Duffy said the exchange would litigate over the approval granted at the end of May.
The core of the complaint is procedural. CME argues the CFTC did not engage in its own analysis of whether Kalshi's Bitcoin perpetual — a contract with no expiry, the defining feature of the perps that dominate offshore crypto trading — fits the legal definition of "future" under the Commodity Exchange Act. The exchange contends the products are "swaps" as defined by Dodd-Frank, and that the CFTC's approval order doesn't even contain the word "swap." "The CFTC did not engage in its own analysis of whether its approval of Kalshi's Bitcoin perpetual as a future is consistent with law," the suit says, adding the agency "rubberstamped Kalshi's application."
Why it matters
It is unusual for an exchange of CME's stature to sue its primary regulator, and the suit lands at a moment when the population of designated contract markets moving into perps is expanding quickly. On the same day the CFTC greenlit Kalshi's application, it sent a no-action letter to Coinbase that effectively opened the door for the exchange to list perps via an offshore intermediary. Former Starkware general counsel Katherine Kirkpatrick Bos argued on X that the CFTC has discretion to categorize novel products with future-like characteristics as futures — but noted there is "no clear precedent" on whether "future delivery" is a strict requirement for that label.
The distinction is not academic: futures and swaps carry different regulatory regimes under Dodd-Frank, including different margin, reporting, and clearing requirements for issuers. CME's wager is that the court will force the CFTC to redo the legal analysis, which could slow — or restructure — how every DCM currently listing or preparing to list perps gets approved.
Market impact
The May data points published alongside the suit underline why the timing matters.
Frequently asked questions
-
What is CME Group suing the CFTC over?
CME is asking a federal court to vacate the CFTC's approval of Kalshi's U.S. perpetual futures contracts, arguing the agency didn't properly analyze whether the products are swaps or futures under Dodd-Frank.
-
Why does CME say Kalshi's perps are swaps, not futures?
Per the complaint, perps lack an expiry, which CME argues makes them "swaps" as defined by Dodd-Frank rather than futures. The approval order, the suit notes, does not contain the word "swap."
-
What does this mean for Coinbase's perpetual futures plans?
The CFTC sent Coinbase a no-action letter the same day it approved Kalshi, opening a path for Coinbase to list perps through an offshore intermediary. CME's legal argument could pressure that route as well.
-
Why is the lawsuit unusual?
It is rare for an exchange as established as CME to sue its primary regulator. CME says the CFTC "rubberstamped" Kalshi's application without engaging in its own statutory analysis under Dodd-Frank.
-
How are perpetual futures volumes trending?
Combined exchange volumes fell 3.45% in May to $4.41 trillion, the lowest since September 2024, while RWA perpetual futures volumes rose 10.4% against that trend to a new all-time high.
CoinDesk